Interestingly, although the analysis of TNF-α (−1,031 T/C) polymorphism did not reveal a significant correlation with the manifestation and progression of clinical characteristics of FMF, a statistically significant difference was observed between patients with and without arthritis or amyloidosis with regard to TNF-α (−308G/A). The gene discussed is TNF; the disease is amyloidosis.